Form 4: MoneyLion Inc. Executive Timmie Hong Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


MoneyLion Inc.'s Chief Product Officer, Timmie Hong, executed sales of Class A Common Stock on September 16, 2024, under a pre-arranged trading plan.

Summary

  • Timmie Hong, Chief Product Officer of MoneyLion Inc., sold shares of Class A Common Stock on September 16, 2024.
  • The sales were executed under a written trading plan adopted on March 14, 2024, intended to comply with Rule 10b5-1(c) of the Securities Exchange Act of 1934.
  • A total of 2,334 shares were sold in multiple transactions at varying prices.
  • The weighted average sale prices ranged from $41.9393 to $44.09 per share.
  • Following the reported transactions, Hong still beneficially owns 105,857 shares of Class A Common Stock, including restricted stock units and performance share units.
  • The reporting person will provide full information regarding the number of shares sold at each separate price upon request.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. It doesn't convey any particularly positive or negative sentiment about the company's prospects.

Positives

  • The sales were conducted under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of insider trading activity and doesn't necessarily reflect broader industry trends. However, it's common for executives to utilize 10b5-1 plans to diversify their holdings and avoid accusations of trading on inside information.

Stakeholder Impact

  • The stock sale by an executive could have a minor negative impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
2024-03-14Date of adoption of the Rule 10b5-1 trading plan.
2024-09-16Date of the reported stock sales.
2024-09-17Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.